• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油三酯/高密度脂蛋白胆固醇比值作为首次急性冠状动脉综合征冠状动脉斑块负荷的一种更优诊断生物标志物

TG/HDL-C Ratio as a Superior Diagnostic Biomarker for Coronary Plaque Burden in First-Time Acute Coronary Syndrome.

作者信息

Aydin Fatih, Murat Bektaş, Murat Selda, Dağhan Hazal

机构信息

Department of Cardiology, Eskisehir City Hospital, 26080 Eskisehir, Türkiye.

Department of Cardiology, Eskisehir Osmangazi University, 26040 Eskisehir, Türkiye.

出版信息

Diagnostics (Basel). 2025 Sep 2;15(17):2222. doi: 10.3390/diagnostics15172222.

DOI:10.3390/diagnostics15172222
PMID:40941709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12428313/
Abstract

: Present ACS risk stratification predominantly depends on LDL-C, yet its diagnostic accuracy for coronary plaque burden remains limited. We examined whether extensive lipid profiling, specifically the TG/HDL-C ratio, could function as a more effective diagnostic instrument for forecasting significant plaque burden in treatment-naïve first-time ACS patients. : Among 722 ACS patients screened, 376 treatment-naïve patients undergoing PCI with complete lipid data were included. Exclusions ( = 346) were due to prior CAD, lipid-lowering therapy, renal/hepatic dysfunction, malignancy, pregnancy, or incomplete data. Coronary plaque burden was quantified by QCA, and patients were stratified by lesion count (0, 1, 2, 3, ≥4). The levels of lipids (LDL-C, HDL-C, TC, TG) and their ratios (LDL/HDL-C, TC/HDL-C, TG/HDL-C) were measured. Analyses included ANOVA (with Bonferroni correction), correlation, ordinal regression, and logistic regression (≥3 vs. <3 lesions). ROC analysis determined thresholds. : TG/HDL-C ratio increased progressively from 3.3 (0 lesions) to 5.3 (≥4 lesions). After Bonferroni correction, only TG/HDL-C retained significance ( = 0.009). Logistic regression confirmed TG/HDL-C as an independent predictor of high plaque burden (OR 1.25, 95% CI 1.09-1.42, = 0.004), outperforming LDL-C. : TG/HDL-C ratio is a superior diagnostic biomarker compared to LDL-C for identifying extensive coronary plaque burden. Integration into admission lipid profiling offers a cost-effective, actionable tool.

摘要

目前急性冠状动脉综合征(ACS)的风险分层主要依赖于低密度脂蛋白胆固醇(LDL-C),但其对冠状动脉斑块负荷的诊断准确性仍然有限。我们研究了全面的血脂分析,特别是甘油三酯/高密度脂蛋白胆固醇(TG/HDL-C)比值,是否能作为一种更有效的诊断工具,用于预测初治首次发生ACS患者的显著斑块负荷。

在722例接受筛查的ACS患者中,纳入了376例接受经皮冠状动脉介入治疗(PCI)且有完整血脂数据的初治患者。排除的346例患者是由于既往有冠心病(CAD)、降脂治疗、肾/肝功能不全、恶性肿瘤、妊娠或数据不完整。通过定量冠状动脉造影(QCA)对冠状动脉斑块负荷进行量化,并根据病变数量(0、1、2、3、≥4)对患者进行分层。测量血脂水平(LDL-C、HDL-C、总胆固醇(TC)、甘油三酯(TG))及其比值(LDL/HDL-C、TC/HDL-C、TG/HDL-C)。分析包括方差分析(采用Bonferroni校正)、相关性分析、有序回归分析和逻辑回归分析(≥3个病变与<3个病变)。通过ROC分析确定阈值。

TG/HDL-C比值从3.3(0个病变)逐渐增加到5.3(≥4个病变)。经过Bonferroni校正后,只有TG/HDL-C具有显著性(P = 0.009)。逻辑回归分析证实TG/HDL-C是高斑块负荷的独立预测因子(比值比[OR]为1.25,95%置信区间[CI]为1.09 - 1.42,P = 0.004),优于LDL-C。

与LDL-C相比,TG/HDL-C比值是识别广泛冠状动脉斑块负荷的更优诊断生物标志物。将其纳入入院时的血脂分析可提供一种具有成本效益且可操作的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/79df8b5e105f/diagnostics-15-02222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/488d0e4efe25/diagnostics-15-02222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/ad618c21b2eb/diagnostics-15-02222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/79df8b5e105f/diagnostics-15-02222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/488d0e4efe25/diagnostics-15-02222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/ad618c21b2eb/diagnostics-15-02222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c9/12428313/79df8b5e105f/diagnostics-15-02222-g003.jpg

相似文献

1
TG/HDL-C Ratio as a Superior Diagnostic Biomarker for Coronary Plaque Burden in First-Time Acute Coronary Syndrome.甘油三酯/高密度脂蛋白胆固醇比值作为首次急性冠状动脉综合征冠状动脉斑块负荷的一种更优诊断生物标志物
Diagnostics (Basel). 2025 Sep 2;15(17):2222. doi: 10.3390/diagnostics15172222.
2
Laboratory-derived inflammatory ratios as a novel diagnostic model for premature coronary artery disease.实验室衍生的炎症比值作为早发性冠状动脉疾病的一种新型诊断模型。
Front Endocrinol (Lausanne). 2025 Aug 27;16:1646944. doi: 10.3389/fendo.2025.1646944. eCollection 2025.
3
Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults.非高密度脂蛋白胆固醇和甘油三酯/高密度脂蛋白胆固醇比值与青年人群冠状动脉斑块负担及斑块特征的相关性。
Bosn J Basic Med Sci. 2022 Oct 23;22(6):1025-1032. doi: 10.17305/bjbms.2022.7142.
4
Comprehensive meta-analysis of the effects of oral medroxyprogesterone acetate plus conjugated equine oestrogens on the lipid profile in women: Insights from randomized controlled trials.口服醋酸甲羟孕酮联合结合型马雌激素对女性血脂谱影响的综合荟萃分析:来自随机对照试验的见解。
Eur J Clin Invest. 2024 Aug;54(8):e14211. doi: 10.1111/eci.14211. Epub 2024 May 10.
5
Evaluation of the Association of the Total Cholesterol-to-High-Density Lipoprotein Cholesterol Ratio and Triglyceride-Glucose Index With Coronary Artery Disease and Their Diagnostic Utility.总胆固醇与高密度脂蛋白胆固醇比值及甘油三酯-葡萄糖指数与冠状动脉疾病的关联评估及其诊断效用
Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-16. doi: 10.12968/hmed.2024.1038. Epub 2025 Jun 13.
6
Clinical utility of lipid ratios as potential predictors of metabolic syndrome among the elderly population: Birjand Longitudinal Aging Study (BLAS).血脂比值作为老年人群代谢综合征潜在预测指标的临床应用:比詹德纵向老龄化研究(BLAS)。
BMC Geriatr. 2023 Jul 3;23(1):403. doi: 10.1186/s12877-023-04040-8.
7
Metabolic Syndrome and Insulin Resistance Are Associated With Normal-Range Aspartate Aminotransferase, Alanine Aminotransferase, and Their Ratio in Chinese Women With Polycystic Ovary Syndrome.代谢综合征和胰岛素抵抗与多囊卵巢综合征中国女性的正常范围天冬氨酸转氨酶、丙氨酸转氨酶及其比值相关。
Clin Endocrinol (Oxf). 2025 Aug 19. doi: 10.1111/cen.70018.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Prognostic Time Frame of Plaque and Hemodynamic Characteristics and Integrative Risk Prediction for Acute Coronary Syndrome.斑块及血流动力学特征的预后时间框架与急性冠状动脉综合征的综合风险预测
JACC Cardiovasc Imaging. 2025 Jul;18(7):784-795. doi: 10.1016/j.jcmg.2025.02.003. Epub 2025 Apr 23.
10
The effect of vitamin D on the lipid profile as a risk factor for coronary heart disease in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials.维生素 D 对血脂谱的影响作为绝经后妇女冠心病的危险因素:一项荟萃分析和随机对照试验的系统评价。
Exp Gerontol. 2022 May;161:111709. doi: 10.1016/j.exger.2022.111709. Epub 2022 Jan 26.

本文引用的文献

1
Apelin-to-total cholesterol ratio predicts long-term major adverse cardiovascular events in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention: a retrospective cohort analysis.阿佩林与总胆固醇比值可预测ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后的长期主要不良心血管事件:一项回顾性队列分析
BMC Cardiovasc Disord. 2025 Jul 4;25(1):478. doi: 10.1186/s12872-025-04949-5.
2
Cost-Effectiveness of the CADScor System in Low-Risk Patients Presenting to the Emergency Department with Chest Pain.CADScor系统在因胸痛就诊于急诊科的低风险患者中的成本效益分析
Pharmacoecon Open. 2025 Jun 23. doi: 10.1007/s41669-025-00590-2.
3
Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI.
接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的甘油三酯与高密度脂蛋白胆固醇比值及主要不良心血管事件
Sci Rep. 2024 Dec 30;14(1):31752. doi: 10.1038/s41598-024-82064-9.
4
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes.急性冠状动脉综合征患者中9型前蛋白转化酶枯草杆菌蛋白酶/克新蛋白酶抑制剂:从降脂、斑块稳定到改善预后
J Clin Med. 2024 Aug 25;13(17):5040. doi: 10.3390/jcm13175040.
5
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.光学相干断层成像术评价秋水仙碱对急性冠状动脉综合征患者冠脉斑块稳定性的影响:COLOCT 随机临床试验。
Circulation. 2024 Sep 24;150(13):981-993. doi: 10.1161/CIRCULATIONAHA.124.069808. Epub 2024 Aug 21.
6
Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome.炎症的作用及秋水仙碱在急性冠脉综合征患者中应用的证据
Front Cardiovasc Med. 2024 Jun 27;11:1356023. doi: 10.3389/fcvm.2024.1356023. eCollection 2024.
7
Recurrent Acute Coronary Syndrome in Young Man with Familial Hypercholesterolemia: Efficacy of Evolocumab Add-On Treatment Demonstrated via Serial Coronary Angiography.家族性高胆固醇血症青年男性复发性急性冠状动脉综合征:通过系列冠状动脉造影证明阿利西尤单抗附加治疗的疗效
Biomedicines. 2024 May 17;12(5):1113. doi: 10.3390/biomedicines12051113.
8
Lipid-Lowering Therapy after Acute Coronary Syndrome.急性冠状动脉综合征后的降脂治疗
J Clin Med. 2024 Apr 1;13(7):2043. doi: 10.3390/jcm13072043.
9
Long-Term Clinical Impact of Patients with Multi-Vessel Non-Obstructive Coronary Artery Disease.多支非阻塞性冠状动脉疾病患者的长期临床影响
Life (Basel). 2023 Oct 26;13(11):2119. doi: 10.3390/life13112119.
10
Superficial Calcified Plates Associated to Plaque Erosions in Acute Coronary Syndromes.急性冠状动脉综合征中与斑块侵蚀相关的浅表钙化斑块
Life (Basel). 2023 Aug 11;13(8):1732. doi: 10.3390/life13081732.